SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- AeRang Kim, MD, PhD
Children's National Research Institute
Principal Investigator - Brigitte Widemann, MD
National Cancer Institute (NCI)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sarcoma Oncology Center
Santa Monica, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Iowa
Iowa City, Iowa, United States
- National Cancer Institute
Bethesda, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University
St Louis, Missouri, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 30 Apr 2018
- Completion
- 31 Jul 2018
- Last update posted
- 15 May 2019
- Registered enrollment
- 20
- Registry id
- NCT02008877
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.